ChIP sequencing of BATF2 in human astrocytes treated with interferon-gamma

Published: 24 January 2025| Version 1 | DOI: 10.17632/394p49bvgd.1
Contributor:
Jessica Williams

Description

Commercially available (ScienCell Research Laboratories) primary human spinal cord astrocytes were treated with 10ng/ml interferon-gamma for 24 hours and chromatin immunoprecipitation sequencing was performed commercially by Active Motif Services using a validated antibody to BATF2 (Proteintech).

Files

Institutions

Cleveland Clinic

Categories

Neuroimmunology

Funding

National Institute of Neurological Disorders and Stroke

R01 NS119178

National Multiple Sclerosis Society

RFA-2203-39228

Licence